Nuveen
OKUR icon

Nuveen’s OnKure Therapeutics OKUR Stock Holding History

Nuveen’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$124K Buy
45,491
+10,089
+28% +$38.1K ﹤0.01% 3946
2026
Q2 		$161K Buy
+35,402
New +$152K ﹤0.01% 3675
2024
Q2 		– Sell
-1,804
Closed -$29.9K – 3430
2024
Q1 		$29.9K Hold
1,804
– – ﹤0.01% 3277
2023
Q4 		$28.9K Buy
1,804
+118
+7% +$7.35K ﹤0.01% 3312
2023
Q3 		$128K Hold
1,686
– – ﹤0.01% 3101
2023
Q2 		$111K Buy
+1,686
New +$136K ﹤0.01% 3154

Other funds holding OKUR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Police & Firemen's Retirement System of New Jersey
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

Nuveen's OKUR Position: Q3 2026 in Review

Nuveen increased its OnKure Therapeutics (OKUR) stake by 28% in Q3 2026, buying an estimated $38.1K and bringing the position to 45,491 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #3946.

Nuveen first reported a position in OKUR in Q2 2023 and has held it in 6 quarters since. The position peaked at $161K in Q2 2026. 18 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

  • Nuveen held 45,491 shares of OnKure Therapeutics worth $124K as of Q3 2026.
  • Nuveen bought 10,089 OnKure Therapeutics shares in Q3 2026, an estimated $38.1K.
  • OnKure Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #3946 holding.
  • Nuveen first reported a position in OnKure Therapeutics in Q2 2023 and has held it in 6 quarters since.
  • Nuveen's OnKure Therapeutics position peaked at $161K in Q2 2026.
  • 18 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.